Misplaced Lens Cap
One Nice Bug Per Day
❣ Chile in a Photography ❣
Claire Keane
h
oozey mess
Cookie Run:Kingdom Official!
No title available
official daine visual archive
Color Me Curious
$LAYYYTER
TMBGareOK. The Official They Might Be Giants tumblr
shark vs the universe
RMH
Discoholic 🪩
taylor price
hello vonnie
tumblr dot com
Origami Around
Product Placement
seen from United States
seen from Jordan
seen from Mexico
seen from Germany
seen from Colombia
seen from Malaysia
seen from Singapore
seen from United States
seen from Brazil
seen from Morocco
seen from United Kingdom
seen from Canada
seen from Türkiye
seen from United States
seen from Tunisia
seen from Mauritius
seen from United States
seen from United States
seen from Kenya
seen from United States
@bharatbiotech-blog
Bharat Biotech Celebrates 20 Years , this video looks back at the beginnings of the company and how it stood for innovation and excellence from its early day...
Bharat Biotech Corporate Film - A leading Biotech Company in India.
Bharat Biotech is delighted to be a part of PEDICON 2020. Come experience our latest Innovations at Stall G3 in the Vaccine Trade Stall Area from 9th – 12th Jan, Brilliant Convention Center, Indore.
Antibiotic resistance is one of the biggest threats to global health leading to higher medical costs, prolonged hospital stays and increased mortality. Join hands in the fight against antibiotic resistance by creating awareness about antibiotics misuse. . . . . #BharatBiotech #antibiotics #antibioticresistance #WAAW2019 #Health #publichealth #WorldAntibioticAwarenessWeek #WAAW #healthforall (at Bharat Biotech) https://www.instagram.com/p/B5HNgXvAQlI/?igshid=oc77pvmrkzx3
Global health officials recently announced the eradication of wild poliovirus type 3 (WPV3) worldwide. WPV3 is the third human disease-causing pathogen eradicated, after smallpox (1980) and wild poliovirus type 2 (2015). https://www.who.int/news-room/feature-stories/detail/two-out-of-three-wild-poliovirus-strains-eradicated . . . . . #BharatBiotech #virus #disease #eradication #poliovirus #immunization #vaccination #vaccineswork #Getvaccinated #health #publichealth #science #innovation #healthforall #GAVI #WHO #TYVAC #PATH #DefeatDD #UNICEF #endpolio #endpolionow #transmission (at Hyderabad, India) https://www.instagram.com/p/B4WVmUVgZHo/?igshid=lm543e60vy09
Dr. Osward Nyirenda & several other frontline health workers continue to work towards creating awareness on the effectiveness of typhoid conjugate vaccine in reducing the disease burden in typhoid-endemic countries like Malawi.
https://www.coalitionagainsttyphoid.org/story-of-typhoid-o…/
Dr HarshaVardhan GVJA from Bharat Biotech spoke on the Introduction to Vaccine and Biologics Industry at the Vaccine Skills Development Programme of TASK, Govt. of Telangana. The event was held at St. Pious X Degree and PG College for Women, Hyderabad on 9 April, 2019.
Dr. Harsha is the Director for Viral Vaccines at Bharat Biotech and has directed the prestigious Rotavirus Vaccine Development Project. He has been one of the key persons behind the development of Oral Polio Vaccine in 1968. He is associated with several national and international organisations related to vaccines.
April 29, 2019: Bharat Biotech International Limited posted images on LinkedIn
Immunization is one of the most successful and cost-effective public health interventions, preventing 2 - 3 million deaths every year, across all age groups. #VaccinesWork to save lives. World Immunization Week 2019.
Immunization is our shield against serious diseases. #VaccinesWork to protect individuals and communities. World Immunization Week 2019.
What’s better than one rotavirus vaccine? Four rotavirus vaccines.
Bharat Biotech ROTAVAC In News.
Dr Harshavardhan Gvja from Bharat Biotech spoke on the Introduction to Vaccine and Biologics Industry at the Vaccine Skills Development Programme of TASK, Govt. of Telangana. The event was held at St. Pious X Degree and PG College for Women, Hyderabad on 9 April, 2019.
Dr. Harsha is the Director for Viral Vaccines at Bharat Biotech and has directed the prestigious Rotavirus Vaccine Development Project. He has been one of the key persons behind the development of Oral Polio Vaccine in 1968. He is associated with several national and international organisations related to vaccines.
Announcing the deal, Dr. Krishna Ella, Chairman and Managing Director of Bharat Biotech, said:
“This acquisition is strategic in helping us enhance our opportunities to achieve greater scale in tackling pub- lic health problems. Bharat Biotech will strengthen its product portfolio and substantially increase product availability in response to the growing demand for this vaccine. With the significant disease burden of rabies in India and other countries, I appreciate GSK’s vision in this transition to Bharat Biotech, to continue to meet the needs of the patients.”
Bharat Biotech International Limited is a multidimensional innovation-oriented, Biotechnology company approved by USFDA, KFDA and WHO in India, focused on the development of novel health care solutions for region-specific infectious diseases. In collaboration and partnership with some of the world's best institutions, BBIL has emerged as the creator of all life-giving Vaccines for Rabies, Japanese Encephalitis (JE), Hepatitis-B, Rotavirus, Typhoid fever,H1N1, diphtheria, tetanus, pertussis, Hib infections, recombinant Hepatitis-B,polio, Hepatitis-B virus infection, Epidermal growth factor.
Dr. Krishna Ella, CMD - Bharat Biotech, moderating a session on Vaccine Development along with Laura Martin of GSK on Day 1 at the 11th International Conference on Typhoid and Other Invasive Salmonelloses at Hanoi, Vietnam.
Together let’s build healthy nation. Pulse Polio Drive, March 10th. #BharatBiotech #polio #Biopolio #vaccine #biopoliob1/3 #sIPV #UIP #vaccinationwork #polioday #India #poliodrops #Health #awareness #NationalimmunizatioDay #staypoliofree #vaccination #WHO #PATH #GAVI #Polio2019 #erradication #savechildren #pulsepolio #immunization https://www.instagram.com/p/Buz1S9FFWao/?utm_source=ig_tumblr_share&igshid=n6p7z2ogrocj
While Bharat Biotech now has a capacity to make 10 million doses, Chiron has 15 million capacity for rabies vaccine
“This acquisition is strategic in helping us enhance our opportunities to achieve greater scale in tackling pub-lic health problems... With the significant disease burden of rabies in India and other countries, I appreciate GSK’s vision in this transition to Bharat Biotech, to continue to meet the needs of the patients.”- Krishna Ella, CMD, Bharat Biotech.
February 2, 2019: Bharat Biotech International Limited posted images on LinkedIn